Prelude Capital Management’s CVS Health CVS Stock Holding History

Prelude Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$1.01M	–	1851
2022 Q1	$1.01M	Hold	10,000	–	–	0.03%	576
2021 Q4	$1.03M	Hold	10,000	–	–	0.03%	588
2021 Q3	$849K	Sell	10,000 -8,000	-44%	-$670K	0.02%	634
2021 Q2	$1.5M	Sell	18,000 -25,000	-58%	-$2.05M	0.04%	414
2021 Q1	$3.23M	Buy	43,000 +27,000	+169%	+$1.97M	0.08%	185
2020 Q4	$1.09M	Buy	+16,000	New	+$1.04M	0.03%	454
2020 Q2	–	Sell	-15,000	Closed	-$890K	–	2003
2020 Q1	$890K	Buy	+15,000	New	+$1M	0.06%	223
2019 Q3	–	Sell	-25,000	Closed	-$1.36M	–	1768
2019 Q2	$1.36M	Hold	25,000	–	–	0.07%	278
2019 Q1	$1.35M	Buy	25,000 +19,200	+331%	+$1.19M	0.08%	265
2018 Q4	$380K	Buy	+5,800	New	+$433K	0.03%	546
2016 Q4	–	Sell	-10,700	Closed	-$952K	–	1591
2016 Q3	$952K	Hold	10,700	–	–	0.1%	221
2016 Q2	$1.02M	Buy	+10,700	New	+$1.07M	0.14%	168

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prelude Capital Management's CVS Position: Q1 2026 in Review

Prelude Capital Management increased its CVS Health (CVS) stake by 339% in Q1 2026, buying an estimated $685K and bringing the position to 11,518 shares worth $827K. The position accounts for 0.06% of the portfolio, ranked #349.

Prelude Capital Management first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $4.1M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Prelude Capital Management held 11,518 shares of CVS Health worth $827K as of Q1 2026.
Prelude Capital Management bought 8,895 CVS Health shares in Q1 2026, an estimated $685K.
CVS Health made up 0.06% of Prelude Capital Management's portfolio in Q1 2026, its #349 holding.
Prelude Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
Prelude Capital Management's CVS Health position peaked at $4.1M in Q1 2022.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.